News
Basilea announces commercial availability of antibiotic Zevtera® (ceftobiprole) in the United States
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today ...
The scalp microbiome comprises diverse bacteria, fungi, and yeast that interact with sebum, pH, and immune responses to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results